Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease
Autor: | Gareb, Bahez, Eissens, Anko C., Kosterink, Jos G.W., Frijlink, Hendrik W. |
---|---|
Zdroj: | In European Journal of Pharmaceutics and Biopharmaceutics June 2016 103:32-42 |
Databáze: | ScienceDirect |
Externí odkaz: |